Sirolimus as a new drug for treatment of RIF patients with elevated Th17/Treg Ratio: a randomized, double-blind, phase II clinical trial

Thumbnail
Date
2018
Author
Ahmadi, M
Danaii, S
Berjis, K
Nouri, M
Yousefi, M
Metadata
Show full item record
URI
http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44173
Collections